300676 华大基因
已收盘 04-30 15:00:00
资讯
新帖
简况
华大基因(300676)3月31日股东户数6.79万户,较上期减少2.62%
证券之星 · 04-27
华大基因(300676)3月31日股东户数6.79万户,较上期减少2.62%
图解华大基因一季报:第一季度单季净利润同比减69.91%
证券之星 · 04-27
图解华大基因一季报:第一季度单季净利润同比减69.91%
华大基因(300676.SZ)发布一季度业绩,净利润1240.25万元,同比减少69.91%
智通财经网 · 04-26
华大基因(300676.SZ)发布一季度业绩,净利润1240.25万元,同比减少69.91%
华大基因(300676.SZ)发布2023年度业绩,净利润9290.04万元,下降88.43%
智通财经网 · 04-12
华大基因(300676.SZ)发布2023年度业绩,净利润9290.04万元,下降88.43%
华大基因业绩快报:2023年净利同比降88.64%
第一财经 · 02-29
华大基因业绩快报:2023年净利同比降88.64%
华大基因(300676.SZ)2023年度净利润9121.1万元 同比下降88.64%
智通财经网 · 02-29
华大基因(300676.SZ)2023年度净利润9121.1万元 同比下降88.64%
被踢出MSCI中国指数,华大基因前景如何?
财华社 · 02-21
被踢出MSCI中国指数,华大基因前景如何?
华大基因:2023年净利同比预降86.3%—90.04%
港股那点事 · 01-30
华大基因:2023年净利同比预降86.3%—90.04%
华大基因(300676.SZ)向18名激励对象授予140万股限制性股票
智通财经网 · 2023-12-01
华大基因(300676.SZ)向18名激励对象授予140万股限制性股票
公司概况
公司名称:
深圳华大基因股份有限公司
所属行业:
专业技术服务业
上市日期:
2017-07-14
主营业务:
深圳华大基因股份有限公司的主营业务为通过基因检测,质谱检测,生物信息分析等多组学大数据技术手段,为科研机构,企事业单位,医疗机构,社会卫生组织等提供研究服务和精准医学检测综合解决方案。公司主要产品包括孕期营养检测、人体氨基酸检测、人体维生素检测等。公司获得了“2019年度中国最受尊敬企业”、“价值合作伙伴奖”、“金牛奖.2018年度投资者关系管理奖”、“中国证券金紫荆奖.最佳IR团队”、“首届A股科技龙头50嘉年华.最佳投资者服务奖”、“全球企业社会责任健康促进奖”、“中国扶贫开发协会脱贫攻坚优秀会员单位”、“2018年度优秀公益项目奖”(宫颈癌防控专项)等多项荣誉,有效提升了公司的影响力和美誉度。公司坚持规范治理与运作,恪守高质量发展的理念,努力践行并承担社会责任,在行业发展、社会公益、资本市场等领域荣获多个奖项。报告期内,公司荣获“2022年度ESG最佳社会责任企业”、“2023医疗器械出海最佳战略布局企业”、“2022年度投资者关系金奖杰出IR公司”,“2023环境、社会及治理(ESG)年度案例”等多项社会荣誉或奖项,有效提升了公司的品牌知名度和影响力。
发行价格:
13.64
{"stockData":{"symbol":"300676","market":"SZ","secType":"STK","nameCN":"华大基因","latestPrice":41.13,"timestamp":1714460589000,"preClose":41.21,"halted":0,"volume":3075800,"delay":0,"floatShares":411000000,"shares":413999999,"eps":0.1546,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.08,"latestTime":"04-30 15:00:00","open":41.39,"high":41.43,"low":40.52,"amount":126000000,"amplitude":0.0221,"askPrice":41.13,"askSize":8,"bidPrice":41.12,"bidSize":14,"shortable":0,"etf":0,"ttmEps":0.1546,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":41.21,"symbolType":"stock","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":45.33,"lowLimit":37.09,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":413914325,"pbRate":1.72,"roa":"--","roe":"0.13%","epsLYR":0.2266,"committee":-0.530457,"marketValue":17024000000,"floatMarketCap":16901000000,"peRate":266.041407,"changeRate":-0.0019,"turnoverRate":0.0075,"status":1},"requestUrl":"/m/hq/s/300676/wiki","defaultTab":"wiki","newsList":[{"id":"2430797422","title":"华大基因(300676)3月31日股东户数6.79万户,较上期减少2.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430797422","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430797422?lang=zh_cn&edition=full","pubTime":"2024-04-27 17:19","pubTimestamp":1714209581,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华大基因披露,截至2024年3月31日公司股东户数为6.79万户,较12月31日减少1822.0户,减幅为2.62%。在医疗服务行业个股中,华大基因股东户数高于行业平均水平,截至3月31日,医疗服务行业平均股东户数为4.14万户。从股价来看,2023年12月31日至2024年3月31日,华大基因区间跌幅为14.73%,在此期间股东户数减少1822.0户,减幅为2.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042700025617.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430535784","title":"图解华大基因一季报:第一季度单季净利润同比减69.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430535784","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430535784?lang=zh_cn&edition=full","pubTime":"2024-04-27 02:11","pubTimestamp":1714155106,"startTime":"0","endTime":"0","summary":"证券之星消息,华大基因2024年一季报显示,公司主营收入8.21亿元,同比下降13.99%;归母净利润1240.25万元,同比下降69.91%;扣非净利润227.76万元,同比下降92.69%;负债率25.37%,投资收益-124.59万元,财务费用-1019.73万元,毛利率49.2%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042700003817.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430136273","title":"华大基因(300676.SZ)发布一季度业绩,净利润1240.25万元,同比减少69.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430136273","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2430136273?lang=zh_cn&edition=full","pubTime":"2024-04-26 19:56","pubTimestamp":1714132611,"startTime":"0","endTime":"0","summary":"华大基因(300676.SZ)发布2024年第一季度报告,公司于报告期内实现营业收...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/astock/23.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/23.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1112168.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426865784","title":"华大基因(300676.SZ)发布2023年度业绩,净利润9290.04万元,下降88.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426865784","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2426865784?lang=zh_cn&edition=full","pubTime":"2024-04-12 20:45","pubTimestamp":1712925900,"startTime":"0","endTime":"0","summary":"华大基因发布2023年年度报告,该公司营业收入为43.5亿元,同比减少38.33%。归属于上市公司股东的净利润为9290.04万元,同比减少88.43%。基本每股收益为0.2266元。报告期内,受行业周期影响,公司相关检测业务收入出现较大下降。公司主动战略性调整主营业务产品结构与供应链策略,报告期内主营业务虽稳步发展,但整体营业收入规模同比缩减。报告期内公司研发投入占营业收入比重较上年同期有较大提升。公司按照权益法核算的投资收益较上年同期大幅下降。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-12/doc-inarqtum8760271.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-12/doc-inarqtum8760271.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2415590469","title":"华大基因业绩快报:2023年净利同比降88.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415590469","media":"第一财经","top":-1,"share":"https://www.laohu8.com/m/news/2415590469?lang=zh_cn&edition=full","pubTime":"2024-02-29 17:22","pubTimestamp":1709198520,"startTime":"0","endTime":"0","summary":" 华大基因2月29日晚间发布业绩快报,2023年实现营业总收入43.53亿元,同比下降38.29%;净利润9121.10万元,同比下降88.64%;基本每股收益0.22元。 华大基因称,公司业绩较2022年度有较大下降,主要系报告期内,受行业周期影响,公司相关检测业务收入出现较大下降。 盘面上,截至今日收盘,华大基因股价报44.22元,涨0.45%。股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-02-29/doc-inakszmk8516888.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-02-29/doc-inakszmk8516888.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2415594025","title":"华大基因(300676.SZ)2023年度净利润9121.1万元 同比下降88.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415594025","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2415594025?lang=zh_cn&edition=full","pubTime":"2024-02-29 16:55","pubTimestamp":1709196900,"startTime":"0","endTime":"0","summary":"华大基因发布2023年度业绩快报,报告期内,公司预计实现营业收入43.53亿元,较上年同期下降38.29%;预计归属于上市公司股东的净利润为9121.1万元,较上年同期下降88.64%。报告期内,公司业绩较2022年度有较大下降,主要系报告期内,受行业周期影响,公司相关检测业务收入出现较大下降。同时积极应对市场变化,加大研发资源投入,保持持续的产品和技术创新,报告期内公司研发投入占营业收入比重较2022年度有较大提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-29/doc-inakszmn9418708.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-29/doc-inakszmn9418708.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2413449054","title":"被踢出MSCI中国指数,华大基因前景如何?","url":"https://stock-news.laohu8.com/highlight/detail?id=2413449054","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2413449054?lang=zh_cn&edition=full","pubTime":"2024-02-21 18:58","pubTimestamp":1708513131,"startTime":"0","endTime":"0","summary":"北京时间2月13日,国际指数编制公司MSCI(明晟指数)宣布了其2024年度2月份的季度指数评审结果,包括华大基因(300676.SZ)在内的多家企业被剔出MSCI中国指数。入选MSCI中国指数的企业意味着较为突出的投资价值,全球基金经理也以MSCI指数作为重要的观察指标,而本次华大基因被剔除该指数,自然被市场解读为悲观的信号。","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202402_1/97de3bc0-d3d8-42e1-9fed-00785ce5e54d.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202402_1/97de3bc0-d3d8-42e1-9fed-00785ce5e54d.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/65d5d76bbde0b37037601b17","is_publish_highlight":false,"gpt_icon":0},{"id":"2407369613","title":"华大基因:2023年净利同比预降86.3%—90.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2407369613","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2407369613?lang=zh_cn&edition=full","pubTime":"2024-01-30 18:48","pubTimestamp":1706611680,"startTime":"0","endTime":"0","summary":"华大基因发布业绩预告,预计2023年归母净利8000万元—1.1亿元,同比下降86.3%—90.04%。业绩预降主要系公司主营业务综合毛利率有所下滑,以及研发投入增长所致。报告期内,受行业周期影响,公司相关检测业务收入较2022年同期出现较大下降,公司继续主动战略性调整主营业务产品结构与供应链策略,推进主营业务的稳步发展。其中,生育健康的业务和多组学的业务收入同比略有增长,肿瘤防控收入同比实现显著增长。 \n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-01-30/doc-inafiecc9998641.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-01-30/doc-inafiecc9998641.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2388234104","title":"华大基因(300676.SZ)向18名激励对象授予140万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2388234104","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2388234104?lang=zh_cn&edition=full","pubTime":"2023-12-01 20:40","pubTimestamp":1701434400,"startTime":"0","endTime":"0","summary":"华大基因(300676.SZ)发布公告,公司审议通过了《关于向2022年限制性股票激励计划激励对象授予预留限制性股票的议案》,确定本激励计划的预留授予日为2023年12月1日,向符合授予条件的18名激励对象授予140万股第二类限制性股票,授予价格为27.83元/股(调整后)。本次授予后,本激励计划预留部分限制性股票全部授予完毕。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-01/doc-imzwpmnn4051103.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-01/doc-imzwpmnn4051103.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-07-14","address":"广东省深圳市盐田区洪安三街21号华大综合园7栋7层-14层","stockEarnings":[{"period":"1week","weight":0.0484},{"period":"1month","weight":0.0049},{"period":"3month","weight":0.0974},{"period":"6month","weight":-0.1589},{"period":"1year","weight":-0.3261},{"period":"ytd","weight":-0.1431}],"companyName":"深圳华大基因股份有限公司","boardCode":"AI0074","perCapita":"6056股","boardName":"专业技术服务业","registeredCapital":"41391万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":" 深圳华大基因股份有限公司的主营业务为通过基因检测,质谱检测,生物信息分析等多组学大数据技术手段,为科研机构,企事业单位,医疗机构,社会卫生组织等提供研究服务和精准医学检测综合解决方案。公司主要产品包括孕期营养检测、人体氨基酸检测、人体维生素检测等。公司获得了“2019年度中国最受尊敬企业”、“价值合作伙伴奖”、“金牛奖.2018年度投资者关系管理奖”、“中国证券金紫荆奖.最佳IR团队”、“首届A股科技龙头50嘉年华.最佳投资者服务奖”、“全球企业社会责任健康促进奖”、“中国扶贫开发协会脱贫攻坚优秀会员单位”、“2018年度优秀公益项目奖”(宫颈癌防控专项)等多项荣誉,有效提升了公司的影响力和美誉度。公司坚持规范治理与运作,恪守高质量发展的理念,努力践行并承担社会责任,在行业发展、社会公益、资本市场等领域荣获多个奖项。报告期内,公司荣获“2022年度ESG最佳社会责任企业”、“2023医疗器械出海最佳战略布局企业”、“2022年度投资者关系金奖杰出IR公司”,“2023环境、社会及治理(ESG)年度案例”等多项社会荣誉或奖项,有效提升了公司的品牌知名度和影响力。","serverTime":1714711149672,"listedPrice":13.64,"stockholders":"67851人(较上一季度减少2.62%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华大基因(300676)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华大基因(300676)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华大基因,300676,华大基因股票,华大基因股票老虎,华大基因股票老虎国际,华大基因行情,华大基因股票行情,华大基因股价,华大基因股市,华大基因股票价格,华大基因股票交易,华大基因股票购买,华大基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华大基因(300676)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华大基因(300676)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}